RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation

Nature

Volumn 540, Issue 7631, 2016, Pages 124-128

  Lin, Juan ^a   Kumari, Snehlata ^a   Kim, Chun ^a   Van, Trieu My ^a   Wachsmuth, Laurens ^a   Polykratis, Apostolos ^a   Pasparakis, Manolis ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; MIXED LINEAGE KINASE; MIXED LINEAGE KINASE LIKE; PHOSPHOTRANSFERASE; PROTEIN KINASE; RECEPTOR INTERACTING PROTEIN KINASE 1; RECEPTOR INTERACTING PROTEIN KINASE 3; UNCLASSIFIED DRUG; Z DNA BINDING PROTEIN 1; GLYCOPROTEIN; MLKL PROTEIN, MOUSE; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; RIPK1 PROTEIN, MOUSE; RIPK3 PROTEIN, MOUSE; ZBP1 PROTEIN, MOUSE;

ADULT; APOPTOSIS; CELLS AND CELL COMPONENTS; EMBRYONIC DEVELOPMENT; ENZYME; MUTATION; PATHOGEN; PROTEIN; RODENT; SKIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DERMATITIS; EMBRYO; ENZYME ACTIVITY; EPIDERMIS; FEMALE; GENE MUTATION; HISTOPATHOLOGY; KERATINOCYTE; LETHALITY; MALE; MEDIATOR; MOUSE; NECROPTOSIS; NONHUMAN; PATHOGENESIS; PERINATAL DEATH; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SKIN DEFECT; ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; CHEMISTRY; DEFICIENCY; GENETICS; INFLAMMATION; METABOLISM; MUTATION; NECROSIS; PATHOLOGY; PHOSPHORYLATION; PROTEIN DOMAIN; SKIN;

MUS;

ANIMALS; APOPTOSIS; GLYCOPROTEINS; INFLAMMATION; KERATINOCYTES; MICE; MUTATION; NECROSIS; PHOSPHORYLATION; PROTEIN DOMAINS; PROTEIN KINASES; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; SKIN;

EID: 85000542319     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature20558     Document Type: Article

References (29)

1. Christofferson, D. E., Li, Y. & Yuan, J. Control of life-or-death decisions by RIP1kinase. Annu. Rev. Physiol. 76, 129-150 (2014).
2. Newton, K. RIPK1 and RIPK3: critical regulators of inflammation and celldeath. Trends Cell Biol. 25, 347-353 (2015).
3. Pasparakis, M. & Vandenabeele, P. Necroptosis and its role in inflammation.Nature 517, 311-320 (2015).
4. Silke, J., Rickard, J. A. & Gerlic, M. The diverse role of RIP kinases in necroptosisand inflammation. Nat. Immunol. 16, 689-697 (2015).
5. Weinlich, R. & Green, D. R. The two faces of receptor interacting proteinkinase-1. Mol. Cell 56, 469-480 (2014).
6. Chan, F. K., Luz, N. F. & Moriwaki, K. Programmed necrosis in the cross talk ofcell death and inflammation. Annu. Rev. Immunol. 33, 79-106 (2015).
7. Lukens, J. R. et al. RIP1-driven autoinflammation targets IL-1 independentlyof inflammasomes and RIP3. Nature 498, 224-227 (2013).
8. Degterev, A. et al. Chemical inhibitor of nonapoptotic cell death withtherapeutic potential for ischemic brain injury. Nat. Chem. Biol. 1, 112-119(2005).
9. He, S. et al. Receptor interacting protein kinase-3 determines cellular necroticresponse to TNF-. Cell 137, 1100-1111 (2009).
10. Wang, L., Du, F. & Wang, X. TNF-induces two distinct caspase-8 activationpathways. Cell 133, 693-703 (2008).
11. Berger, S. B. et al. Cutting Edge: RIP1 kinase activity is dispensable for normaldevelopment but is a key regulator of inflammation in SHARPIN-deficientmice. J. Immunol. 192, 5476-5480 (2014).
12. Polykratis, A. et al. Cutting edge: RIPK1 Kinase inactive mice are viable andprotected from TNF-induced necroptosis in vivo. J. Immunol. 193, 1539-1543(2014).
13. Cho, Y. S. et al. Phosphorylation-driven assembly of the RIP1-RIP3 complexregulates programmed necrosis and virus-induced inflammation. Cell 137,1112-1123 (2009).
14. Dannappel, M. et al. RIPK1 maintains epithelial homeostasis by inhibitingapoptosis and necroptosis. Nature 513, 90-94 (2014).
15. Dillon, C. P. et al. RIPK1 blocks early postnatal lethality mediated by caspase-8and RIPK3. Cell 157, 1189-1202 (2014).
16. Kaiser, W. J. et al. RIP1 suppresses innate immune necrotic as well as apoptoticcell death during mammalian parturition. Proc. Natl Acad. Sci. USA 111,7753-7758 (2014).
17. Rickard, J. A. et al. RIPK1 regulates RIPK3-MLKL-driven systemic inflammationand emergency hematopoiesis. Cell 157, 1175-1188 (2014).
18. Takahashi, N. et al. RIPK1 ensures intestinal homeostasis by protecting theepithelium against apoptosis. Nature 513, 95-99 (2014).
19. Kaiser, W. J., Upton, J. W. & Mocarski, E. S. Receptor-interacting proteinhomotypic interaction motif-dependent control of NF-B activation via theDNA-dependent activator of IFN regulatory factors. J. Immunol. 181,6427-6434 (2008).
20. Rebsamen, M. et al. DAI/ZBP1 recruits RIP1 and RIP3 through RIPhomotypic interaction motifs to activate NF-B. EMBO Rep. 10, 916-922(2009).
21. Takaoka, A. et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activatorof innate immune response. Nature 448, 501-505 (2007).
22. Schwartz, T., Behlke, J., Lowenhaupt, K., Heinemann, U. & Rich, A. Structure ofthe DLM-1-Z-DNA complex reveals a conserved family of Z-DNA-bindingproteins. Nat. Struct. Biol. 8, 761-765 (2001).
23. Fu, Y. et al. Cloning of DLM-1, a novel gene that is up-regulated inactivated macrophages, using RNA differential display. Gene 240, 157-163(1999).
24. Upton, J. W., Kaiser, W. J. & Mocarski, E. S. DAI/ZBP1/DLM-1 complexes withRIP3 to mediate virus-induced programmed necrosis that is targeted bymurine cytomegalovirus vIRA. Cell Host Microbe 11, 290-297 (2012).
25. Ishii, K. J. et al. TANK-binding kinase-1 delineates innate and adaptive immuneresponses to DNA vaccines. Nature 451, 725-729 (2008).
26. Bonnet, M. C. et al. The adaptor protein FADD protects epidermal keratinocytesfrom necroptosis in vivo and prevents skin inflammation. Immunity 35,572-582 (2011).
27. Kelliher, M. A. et al. The death domain kinase RIP mediates the TNF-inducedNF-B signal. Immunity 8, 297-303 (1998).
28. Meng, L., Jin, W. & Wang, X. RIP3-mediated necrotic cell death acceleratessystematic inflammation and mortality. Proc. Natl Acad. Sci. USA 112,11007-11012 (2015).
29. Kuriakose, T. et al. ZBP1/DAI is an innate sensor of influenza virus triggeringthe NLRP3 inflammasome and programmed cell death pathways.Sci. Immunol. 1, aag2045-aag2045 (2016).